Zymeworks Inc. (ZYME) stock forecast and price target
Price $26.24 · data as of November 13, 2026
12-month price target
Gold marker: average target · white marker: today’s price ($26.24)
Analyst ratings
Earnings and revenue estimates
| Period | EPS estimate | EPS growth | Revenue estimate |
|---|---|---|---|
| Current fiscal year ends December 31, 2026 | $1.51 | +239.4% | $339M |
| Next fiscal year ends December 31, 2027 | $0.30 | −80.3% | $348M |
| Next quarter ends December 31, 2026 | $2.19 | +497.3% | $78M |
| Quarter after ends December 31, 2026 | $-0.20 | +63.6% | $26M |
Consensus of the analysts covering Zymeworks, updated daily. In the last 30 days 3 estimates were raised and 1 lowered.
Our model vs. Wall Street
Analysts see 65.0% upside over 12 months. Our discounted cash flow model with moderate assumptions puts Zymeworks’s intrinsic value about 91% below today’s market value, and it scores 1.0 out of 5 on our checks. Price targets follow sentiment; a DCF follows cash. When both point the same way the signal is stronger. Try your own assumptions.
Frequently asked questions
What is the Zymeworks stock price target?
The average 12-month target from 14 analysts is $43.29, 65.0% above the current price of $26.24 Targets range from $35.00 to $60.00.
Is Zymeworks a buy according to analysts?
The consensus rating is “Strong buy” (2 strong buy, 12 buy). Ratings are opinions, not guarantees; this is not investment advice.
How much is Zymeworks expected to earn?
Analysts expect EPS of $1.51 for the fiscal year ending December 31, 2026 and $0.30 the year after.
Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.